Free equity investment tool of Japanese companies

Credit Rating Analysis

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

廣貫堂

Nippon Shikizai

KOEI CHEMICAL

Carna Biosciences

Kawaguchi Chemical Industry

小野産業

New Japan Chemical

TAOKA CHEMICAL

TAIHEI CHEMICALS

LTT Bio-Pharma

日本化学工業

ダイトーケミックス

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Nissan Motor

PIONEER etc.

ROHM

SANKEI CHEMICAL

メルコホールディングス

Credit Rating Analysis: 廣貫堂 (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

Credit Rating (Bankruptcy Risk): 廣貫堂 (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2012-03-31	CC	Credit is very vulnerable.	¥ 13 B 1.07%	¥ -467 M -155.91%	¥ -827 M -62.71%

Financial Timeline

Date	-  (First quarter )	-  (Third quarter )	2011-09-30  (Second quarter )	2012-03-31  (Annual )
Credit Rating	-	-	C	CC
Total Assets	-	-	¥ 18 B	¥ 18 B
Net Assets	-	-	¥ 7 B	¥ 7 B

Financial Statement Risk Analysis: 廣貫堂 (Annual ) (Consolidated )

Special note

Net income has dropped 4 consecutive terms. The business have high risk.

The change of Net income is going too far. The management situation is unstable.

Net Assets have dropped 4 consecutive terms. The fiscal base is getting worse.

[Date: 2012-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -827 M) is minus or 0, so , there is a possibility that the management situation is severe.

Management Risk (*Net Income is decrease )
Net Income (¥ -827 M) is first term Net Income (¥ -508 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-6.09％) is first term Net Profit Margin (-3.78％) less , there is a possibility that the profitability has deteriorated.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 13 B) is first term (¥ 13 B) more, however Operating Cash Flow (¥ 473 M) is first term (¥ 2 B) less , there is a possibility that the financing has deteriorated very much.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 864 M) is Sales first term ratio (¥ 144 M) more , there is a possibility that the non-performing asset was increased.

[Date: 2011-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -508 M) is minus or 0, so , there is a possibility that the management situation is severe.

Management Risk (*Net Income is decrease )
Net Income (¥ -508 M) is first term Net Income (¥ 57 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-3.78％) is first term Net Profit Margin (0.45％) less , there is a possibility that the profitability has deteriorated.

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -1 B) & Financial Cash Flow (¥ -675 M) is a minus, Operating Cash Flow (¥ 2 B) is a plus,

Dividend Risk
Under the situation of Net Income (¥ -508 M) & Operating Cash Flow (¥ 2 B), Dividend (¥ -65 M) is paid.

[Date: 2010-03-31]  Danger : Warning : Caution : Good

Management Risk (*Sales is decrease )
Sales (¥ 12 B) is first term Sales (¥ 13 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Income is decrease )
Net Income (¥ 57 M) is first term Net Income (¥ 626 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (0.45％) is first term Net Profit Margin (4.76％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ 57 M) & Operating Cash Flow (¥ 1 B) , Dividend (¥ -65 M) is paid.

Financing Risk (*Interest-bearing Debt more)
Sales first term ratio (¥ -336 M) & Operating Cash Flow first term ratio (¥ -96 M) is a minus, Interest-bearing Debt (¥ 7 B) is first term Interest-bearing Debt (¥ 5 B) more , there is a possibility that the financing has deteriorated very much.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 98 M) is Sales first term ratio (¥ -336 M) more , there is a possibility that the non-performing asset was increased.

[Date: 2009-03-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 626 M) & Operating Cash Flow (¥ 1 B) , Dividend (¥ -50 M) is paid.

Credit Rating (Bankruptcy Risk): 廣貫堂 (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2012-03-31	CC	Credit is very vulnerable.	¥ 10 B 0.18%	¥ -750 M -252.49%	¥ -1 B -56.99%

Financial Timeline

Date	-  (First quarter )	-  (Third quarter )	2011-09-30  (Second quarter )	2012-03-31  (Annual )
Credit Rating	-	-	C	CC
Total Assets	-	-	¥ 18 B	¥ 17 B
Net Assets	-	-	¥ 7 B	¥ 6 B

Financial Statement Risk Analysis: 廣貫堂 (Annual ) (Non-Consolidated )

Special note

Net income has dropped 4 consecutive terms. The business have high risk.

The change of Net income is going too far. The management situation is unstable.

Net Assets have dropped 4 consecutive terms. The fiscal base is getting worse.

[Date: 2012-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -1 B) is minus or 0, so , there is a possibility that the management situation is severe.

Management Risk (*Net Income is decrease )
Net Income (¥ -1 B) is first term Net Income (¥ -650 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-9.54％) is first term Net Profit Margin (-6.09％) less , there is a possibility that the profitability has deteriorated.

Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 546 M) is Sales first term ratio (¥ 19 M) more , there is a possibility that the non-performing asset was increased.

[Date: 2011-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -650 M) is minus or 0, so , there is a possibility that the management situation is severe.

Management Risk (*Net Income is decrease )
Net Income (¥ -650 M) is first term Net Income (¥ -164 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-6.09％) is first term Net Profit Margin (-1.59％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ -650 M) & Operating Cash Flow (-) , Dividend (¥ -65 M) is paid.

[Date: 2010-03-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -164 M) is minus or 0, so , there is a possibility that the management situation is severe.

Management Risk (*Sales is decrease )
Sales (¥ 10 B) is first term Sales (¥ 10 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Income is decrease )
Net Income (¥ -164 M) is first term Net Income (¥ 207 M) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-1.59％) is first term Net Profit Margin (2.00％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ -164 M) & Operating Cash Flow (-) , Dividend (¥ -65 M) is paid.

[Date: 2009-03-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 207 M) & Operating Cash Flow (-) , Dividend (¥ -50 M) is paid.

Related Information: 廣貫堂 (Annual )

Statement Type

Annual : 廣貫堂

Second quarter : 廣貫堂

Analysis Menu

Outline : 廣貫堂

Statement : 廣貫堂

Rating : 廣貫堂

Indicator : 廣貫堂

Download : 廣貫堂

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Toyama - EDIUNET Prefectures

Toyama富山市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
廣貫堂			Chemicals	3	Annual	CC

Related Company

Kawaguchi Chemical Industry (Sales ¥ 6 B)

New Japan Chemical (Sales ¥ 28 B)

LTT Bio-Pharma (Sales ¥ 61 M)

日本化学工業 (Sales ¥ 32 B)

TAOKA CHEMICAL (Sales ¥ 17 B)

小野産業 (Sales ¥ 3 B)

KOEI CHEMICAL (Sales ¥ 18 B)

ダイトーケミックス (Sales ¥ 8 B)

Carna Biosciences (Sales ¥ 510 M)

TAIHEI CHEMICALS (Sales ¥ 5 B)

Nippon Shikizai (Sales ¥ 7 B)

廣貫堂 (Sales ¥ 13 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .